Piramal Group Overview

  • Year Founded
  • 1980

Year Founded

  • Status
  • Public

  • Employees
  • 12,463


  • Stock Symbol
  • 500302

Stock Symbol

  • Investments
  • 49

  • Share Price
  • $11.28
  • (As of Friday Closing)

Piramal Group General Information


Piramal Enterprises Ltd is a global business conglomerate with an interest in financial services and real estate. The company offers a wide range of financial products and solutions, with exposure across both Retail and Wholesale lending.

Contact Information

Formerly Known As
Nicholas Piramal India Limited
Ownership Status
Publicly Held
Financing Status
Primary Industry
Consumer Finance
Other Industries
Specialized Finance
Stock Exchange
Corporate Office
  • Agastya Corporate Park, Opposite Fire Brigade
  • Kamani Junction, LBS Marg, Kurla (West)
  • Mumbai, Maharashtra 400070
  • India
+91 022 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Piramal Group Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$11.28 $11.03 $7.67 - $13.73 $2.54B 225M 116K -$1.04

Piramal Group Financials Summary

In Thousands,
TTM 31-Dec-2023 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021
EV 8,020,949 6,884,922 13,437,679 8,343,986
Revenue 974,122 1,020,379 1,032,550 1,716,502
EBITDA 21,965 1,078,669 751,280 534,388
Net Income (244,205) 1,241,450 258,109 179,078
Total Assets 10,201,111 13,170,929 10,500,105
Total Debt 0 6,030,481 7,312,704 5,385,884
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Piramal Group Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Piramal Group‘s full profile, request access.

Request a free trial

Piramal Group Patents

Piramal Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210114977-A1 An improved asymmetric synthesis of alpha-branched chiral amines Active 18-Apr-2018 0000000000
US-20210061752-A1 An improved asymmetric synthesis of alpha-(diarylmethyl) alkyl amines Active 21-Mar-2018 0000000000
JP-2021510144-A Improved method of manufacturing droxidopa and its intermediates Pending 04-Jan-2018 0000000000
EP-3436426-A1 An improved process for the preparation of droxidopa and its intermediate Inactive 30-Mar-2016 000000000
EP-3436426-A4 An improved process for the preparation of droxidopa and its intermediate Inactive 30-Mar-2016 C07B53/00
To view Piramal Group’s complete patent history, request access »

Piramal Group Executive Team (27)

Name Title Board Seat Contact Info
Kalpesh Kikani Chief Executive Officer- Piramal Alternatives
Yesh Nadkarni Chief Executive Officer, Wholesale Lending
Vivek Valsaraj Co-President & Chief Financial Officer- Piramal Pharma
Viral Gandhi Co-President & Group Chief Information Officer
Jatin Lal President - Mergers and Acquisitions, Piramal Pharma
You’re viewing 5 of 27 executive team members. Get the full list »

Piramal Group Board Members (13)

Name Representing Role Since
0000 0000000 Piramal Group Chairman and Executive Director 000 0000
00000 000000 Piramal Group Board Member 000 0000
000000 00000000 Self Independent Director 000 0000
0000000 0000000 Piramal Pharma Chairman & Board Member 000 0000
000000000 000000 Piramal Group Director and Chairman of the Audit & Risk Management, Nomination & Remuneration, Stakeholders Relationship and Corporate Social Responsibility Committee 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Piramal Group Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Piramal Group Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Piramal Group‘s full profile, request access.

Request a free trial

Piramal Group Investments & Acquisitions (49)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Annapurna Finance 24-Jan-2024 000000000 000.00 Consumer Finance
KMC Construction 24-Mar-2023 0000000000 Construction and Engineering
Dewan Housing Finance Corporation 29-Sep-2021 0000000000 00.000 Specialized Finance
Convergence Chemicals 25-Feb-2021 0000000000 00.000 Specialty Chemicals
G&W Laboratories (Solid Oral Dosage Drug manufacturing facility in Sellersville, Pennsylvania) 01-Sep-2020 Corporate Asset Purchase 000.00 Buildings and Property 00000 000
You’re viewing 5 of 49 investments and acquisitions. Get the full list »

Piramal Group Subsidiaries (7)

Company Name Industry Location Founded
Convergence Chemicals Specialty Chemicals Dahej, India 2014
Pel Healthcare Pharmaceuticals Sellersville, PA 0000
Piramal Healthcare Pharmaceuticals Bethlehem, PA 0000
Gablofen Pharmaceuticals Saint Paul, MN 0000
Piramal Pharma Solutions BPO/Outsource Services Lexington, KY 0000
You’re viewing 5 of 7 subsidiaries. Get the full list »

Piramal Group ESG

Risk Overview

Risk Rating

Updated September, 01, 2023

16.84 | Low Risk

Risk Scale

A lower score indicates better sustainability












Exposure refers to the extent to which a company is exposed to different material ESG issues



Management is related to actions taken to manage ESG issues


Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.


Covered Companies

00 of 15,605




Diversified Financials


00 of 895




Multi-Sector Holdings


00 of 70




To view Piramal Group’s complete esg history, request access »

Piramal Group Exits (10)

Company Name Exit Date Exit Type Exit Size Status Buyers
Utoo Cabs 12-Jul-2016 000000000 Completed
  • 2 buyers
Essel Green Energy 29-Mar-2016 00 000000000000000 00000 Completed
  • 2 buyers
Health SuperHiway 17-Apr-2015 00000 00000 00 0000 Completed
  • 0000000 00000
PGP Glass 28-Jul-2014 000000000000000000 Completed
  • 0000000 00000
Shriram Transport Finance Company 10-May-2013 Secondary Transaction - Private 00000 Completed
You’re viewing 5 of 10 exits. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »